Beijing – September 20, 2026 -- Chinese President Xi Jinping has ordered sustained expansion of advanced manufacturing, calling for smart, green and integrated industrial upgrading to strengthen supply-chain self-sufficiency, according to instructions conveyed at a national conference on advanced manufacturing in Beijing reported by Xinhua News Agency.

Ras Al Khaimah – September 20, 2026 -- ARIDGE, formerly XPENG AEROHT and Asia's largest flying car company, has signed a strategic cooperation agreement with the Emirate of Ras Al Khaimah to establish what both parties describe as the world's first regulatory sandbox dedicated to personal low-altitude flight.

Rochester, Mich. – September 20, 2026 -- Par Health is voluntarily recalling two lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection 400 mcg/100 mL (4 mcg/mL) at the hospital level after detecting particulate matter identified as cellulose or stopper material.

Sacramento – September 20, 2026 -- California Governor Gavin Newsom signed an executive order accelerating implementation of SB 813, the Fathom-sponsored law that established the nation's first comprehensive framework for independent verification organizations (IVOs) overseeing frontier AI systems.

New York – September 20, 2026 -- Invictus Pharmacy has secured LegitScript Healthcare Merchant Certification for its platform InvictusPharmacy.com, joining a select group of digital pharmacy operators that includes Amazon Pharmacy in meeting the certifier's compliance standards.

Washington – September 20, 2026 -- The American Association of Kidney Patients (AAKP) has endorsed Health and Human Services Secretary Robert F. Kennedy Jr.'s new appointments to the U.S. Preventive Services Task Force (USPSTF), following a years-long campaign by the group to force reforms on kidney disease screening policy. AAKP President Edward V. Hickey III said the appointees bring the diverse credentials needed to advance patient-centered medicine after what the organization calls two decades of Task Force inaction on kidney health.

Indianapolis – September 20, 2026 -- The U.S. Food and Drug Administration has granted full approval to Eli Lilly and Company's (NYSE: LLY) Inluriyo (imlunestrant) in combination with Verzenio (abemaciclib) for adults with estrogen receptor-positive (ER+), HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer whose disease progressed after at least one line of endocrine therapy.

Mexico City – September 20, 2026 -- The Association for the Accreditation of Human Research Protection Programs (AAHRPP) has awarded full accreditation to Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ), making it the first of Mexico's 13 National Institutes of Health under the Mexican Ministry of Health to reach this status.

Norcross, Ga. – September 20, 2026 -- Koning Health's Breast CT System, the CBCT 1000, has been added to the Australian Register of Therapeutic Goods (ARTG No. 531059), clearing the device for commercial supply in Australia.

TGA approves device inclusion on September 8, 2026

The Therapeutic Goods Administration granted the ARTG listing on September 8, 2026, allowing Koning Health to begin commercial supply in Australia subject to regulatory conditions tied to the inclusion.

Helsinki – September 19, 2026 -- Finland's Financial Supervisory Authority approved a supplement to UPM-Kymmene Corporation's demerger and listing prospectus on September 18, 2026, formalizing Lasse von Hertzen's appointment as permanent Chief Financial Officer of WISA Group Plc, the entity being spun off from UPM.